- Cupid’s recent surge is fueled by raised FY27 guidance exceeding ₹800 crore revenue, strong quarterly momentum, and capacity expansions. Its inclusion in the Nifty Smallcap 250 also drove high trading volumes.
- This momentum rests on solid fundamentals and good liquidity. But with high valuations and small-cap volatility, the company must keep delivering on its guidance to sustain its position.
- After gaining over 230% year-to-date, any further upside will depend on execution. New buyers face higher risk, though current holders might still benefit from multi-year growth targets.
Nashik-based Cupid Limited, which makes personal care and healthcare products, has seen its shares deliver strong returns lately.
Its shares jumped over 12% in the last five trading sessions and about 25% in the past month, hitting new 52-week highs near ₹355. The stock’s already up over 230% year-to-date, adding to its multi-year growth trend.
Strong Guidance and Operational Momentum
Much of this recent share price climb comes from management’s updated higher full-year financial outlook. In late September, Cupid announced its second-quarter revenue for FY27 would likely top ₹200 crore.
With steady demand in both domestic FMCG and international healthcare, the company has now boosted its FY27 revenue forecast past ₹800 crore and its net profit forecast above ₹250 crore.
The company’s addition to major benchmark indices, like the FTSE Emerging Markets All Cap Index and the Nifty Smallcap 250 Index, has also drawn substantial passive fund investments. Analysts believe these inclusions could bring in about $10 million in direct institutional money.
Cupid’s stock has even outpaced the broader market and its FMCG sector rivals during a time when the Sensex and Nifty 500 faced downward pressure. This shows its relative market strength.
How Stable Is the Momentum?
Looking back helps put things in perspective. In January, Cupid hit a record near ₹525 after a 15-session winning streak and a 4:1 bonus issue.
Yet by March, even with strong quarterly results, the stock dropped 11% for the year. This shows that solid earnings don’t always protect a stock from sharp corrections.
The company’s promoters own about 46% of its shares, while foreign institutions hold roughly 4%. This limited institutional ownership means the stock price can swing wildly if retail investors change their minds.
A positive development is that the percentage of promoter shares pledged dropped from 36.13% to 20%, easing a past governance worry.
Even though ongoing institutional investments and index inclusions provide some liquidity, the stock’s quick price jump leaves it open to profit-taking or periods where it just consolidates.
Is It Too Late to Buy?
With year-to-date gains over 230% and multi-year returns in the thousands of percent, it’s fair to wonder if now’s the right time to invest. The stock’s forward price-to-earnings ratio is over 300 times its trailing earnings, suggesting a hefty valuation premium.
These high multiples mean the company must perfectly execute its guidance, otherwise, its valuation could see significant drops.
Still, history shows that companies with fast earnings growth can keep delivering investor returns, even after big price jumps, as long as that projected growth actually happens.
The company’s stock jumped after it raised its FY27 guidance to over ₹800 crore revenue and ₹250 crore profit. Strong Q2 results and its inclusion in the Nifty Smallcap 250 also boosted investor interest.
Yes, they are. Successive strong quarters, more capacity, and better guidance all build a strong base. But with high valuations, the company will need to keep performing well.
That depends on your risk tolerance. The growth outlook still looks positive. However, the higher price means there’s less room for mistakes compared to earlier stages.